Biotech

All Articles

Arch finalizes $3B-plus fund to encourage biopharma startups

.On the heels of a $3 billion fund from Bain Capital Lifestyle Sciences, Arc Project Partners is act...

Orion to utilize Aitia's 'digital identical twins' to locate brand-new cancer cells drugs

.Finnish biotech Orion has snooped prospective in Aitia's "electronic double" tech to develop brand-...

Windtree's shock med raises high blood pressure in most recent period 2 succeed

.While Windtree Therapeutics has actually had a hard time to expand the monetary roots required to m...

2 cancer biotechs combine, making international footprint

.OncoC4 is actually taking AcroImmune-- and also its own internal scientific manufacturing functiona...

Amgen files first phase 3 gain for $400M chronic eczema medicine

.Amgen has actually shared (PDF) the initial phase 3 data on its own $400 thousand dermatitis medica...

Biogen, UCB document period 3 lupus succeed after stopping working earlier trial

.Biogen as well as UCB's bet one's bottom dollar improving right into stage 3 on the back of a faile...

Aptadir really hopes brand new RNA preventions may turn around difficult cancers cells

.Italian biotech Aptadir Rehabs has introduced along with the pledge that its own pipe of preclinica...

Wave surfs DMD excellence to regulators' doors, delivering stock up

.Wave Life Sciences has actually fulfilled its objective in a Duchenne muscular dystrophy (DMD) rese...

Sanofi picks brand new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma layer, tak...

Achilles drops cell therapy course, braces for discharges after overlooking 'business practicality' targets

.Achilles Therapies has actually torn up its own approach. The British biotech is actually quiting w...